Targeting IL-1B synergizes with PD-1 blockade for enhanced T and B cell immune responses and inhibition of early lung cancer development

被引：0
|
作者：
Treekitkarnmongkol, Warapen
Han, Guangchun
Rahal, Zahraa
Feng, Jiping
Sinjab, Ansam
Cascone, Tina
Stevenson, Christopher S.
Sweeney, Cheryl
Edwards, Matt
Spira, Avrum
Fujimoto, Junya
Moghaddam, Seyed Javad
Wang, Linghua
Kadara, Humam
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5104
引用
收藏
页数：3
相关论文
共 50 条
  • [1] VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses
    Peled, Michael
    Tocheva, Anna S.
    Adam, Kieran
    Mor, Adam
    [J]. IMMUNOLOGY LETTERS, 2021, 233 : 42 - 47
  • [2] CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner
    Zhang, Qian-Feng
    Li, Jia
    Jiang, Kuo
    Wang, Rui
    Ge, Jun-li
    Yang, Hong
    Liu, Shu-Juan
    Jia, Lin-Tao
    Wang, Lei
    Chen, Bi-Liang
    [J]. THERANOSTICS, 2020, 10 (23): : 10619 - 10633
  • [3] Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
    Wang, Man
    Zhu, Lijie
    Yang, Xiaoxu
    Li, Jiahui
    Liu, Yu'e
    Tang, Ying
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
    Xu-Monette, Zijun Y.
    Zhou, Jianfeng
    Young, Ken H.
    [J]. BLOOD, 2018, 131 (01) : 68 - 83
  • [5] B cell immunology predict response and survival in PD-1/PD-L1 targeting immune checkpoint inhibition of metastatic breast cancer
    Fremd, Carlo
    Schulze, Markus
    Cetin, Miray
    Boehm, Hannah
    Lenoire, Benedicte
    Akilli-Oeztuerk, Oezlem
    Zornig, Inka
    Charoentong, Pornpimol
    Lyu, Yanhong
    Hubschmann, Daniel
    Hubschmann, Daniel
    Kommoss, Felix
    Thewes, Verena
    Schneeweiss, Andreas
    Zapatka, Marc
    Hartmann, Felix
    Lichter, Peter
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [6] PD-1 Blockade in Early-Stage Lung Cancer
    Rosner, Samuel
    Reuss, Joshua E.
    Forde, Patrick M.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 425 - 435
  • [7] PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
    Aaron Goodman
    Sandip P. Patel
    Razelle Kurzrock
    [J]. Nature Reviews Clinical Oncology, 2017, 14 : 203 - 220
  • [8] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
  • [9] PD-1:PD-1 ligand interactions suppress B-1b cell responses to T cell-independent type 2 antigens
    Haas, Karen
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186
  • [10] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
12345